Related Experiment Videos
Male breast cancer
1Department of Surgery, Dartmouth-Hitchcock Medical Center, Hanover, New Hampshire.
The Surgical Clinics of North America
|October 1, 1990
Summary
Male breast cancer, though rare, requires prompt diagnosis and treatment. Early detection is improving, but metastasis to axillary nodes remains a challenge, impacting survival rates and treatment strategies.
Area of Science:
- Oncology
- Medical research
Background:
- Male breast cancer is an uncommon malignancy.
- Early diagnosis is increasingly common, yet many patients present with metastatic disease.
- Axillary lymph node metastasis significantly reduces survival rates.
Purpose of the Study:
- To review current diagnostic and therapeutic approaches for male breast cancer.
- To discuss management strategies for localized and disseminated disease.
- To evaluate the role of hormonal therapy in male breast cancer treatment.
Main Methods:
- Review of existing literature on male breast cancer diagnosis and treatment.
- Analysis of therapeutic options including surgery, radiation, hormonal therapy, and chemotherapy.
- Evaluation of treatment outcomes and patient acceptability.
Main Results:
- Surgical options for localized disease lack a definitive consensus.
- Radiation therapy is recommended for patients with axillary node metastases.
- Tamoxifen is emerging as a preferred treatment over orchiectomy for disseminated disease, particularly in estrogen-receptor-positive cases, due to efficacy and tolerability.
Conclusions:
- Despite advances, optimal surgical management for localized male breast cancer remains debated.
- Adjuvant hormonal therapy, specifically tamoxifen, shows promise for disseminated disease, offering a favorable risk-benefit profile.
- Further research is needed to clarify the roles of adjuvant chemotherapy and optimize treatment protocols.